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 . Therapeutic grade DNA molecules requires the escape from the endosomal pathway to the 
cytosol.  
 . Gelatin B is an interesting candidate to be used for the effective intracellular delivery.  
 . pH-triggered release systems have been achieved through the formation of gelatin B 
(DNA)-PS nanoparticles. 
 . Gelatin-based nanoparticles as potent and non-toxic intracellular delivery systems. 
Abstract   
The rapidly rising demand for therapeutic grade DNA molecules requires associated 
improvements in encapsulation and delivery technologies. One of the challenges for the 
efficient intracellular delivery of therapeutic biom lecules after their cell internalization by 
endocytosis is to manipulate the non-productive trafficking from endosomes to lysosomes, 
where degradation may occur. The combination of theendosomal acidity with the 
endosomolytic capability of the nanocarrier can increase the intracellular delivery of many 
drugs, genes and proteins, which, therefore, might en ance their therapeutic efficacy.  Among 
the suitable compounds, the gelification properties of gelatin as well as the strong dependence 
of gelatin ionization with pH makes this compound an interesting candidate to be used to the 
effective intracellular delivery of active biomacrom lecules. In the present work, gelatin 
(either high or low gel strength) and protamine sulfate has been selected to form particles by 
interaction of oppositely charged compounds. Particles in the absence of DNA (binary 
system) and in the presence of DNA (ternary system) have been prepared. The 
physicochemical characterization (particle size, polydispersity index and degree of DNA 
entrapment) have been evaluated. Cytotoxicity experiments have showed that the isolated 
systems and the resulting gelatin-based nanoparticles are essentially non-toxic. The pH-
dependent hemolysis assay and the response of the nanoparticles co-incubated in buffers at 
defined pHs that mimic extracellular, early endosomal and late endo-lysosomal environments 
demonstrated that the nanoparticles tend to destabilize and DNA can be successfully released. 
It was found that, in addition to the imposed compositi ns, the gel strength of gelatin is a 
controlling parameter of the final properties of these nanoparticles. The results indicate that 
these gelatin-based nanoparticles have excellent properties as highly potent and non-toxic 
intracellular delivery systems, rendering them promising DNA vehicles to be used as non-
viral gene delivery systems.  
Keywords: DNA, nanoparticles, DNA entrapment, endosomolytic es ape, haemolyisis, in 
vitro cytotoxicity 
1. Introduction 
The success in the application of nanomedicines and ge e therapy is largely dependent on 
the development of the vectors that can selectively and efficiently deliver the gene or 
therapeutic agents to the target cells with minimal toxicity [1]. Despite the efforts given in 
vector technology, development of methods for efficient and protected delivery of therapeutic 
agents to the target cells still remains a main issue [2]. Owing to the size and charge of naked 
DNA and the enzymatic and membrane barriers imposed by the cell, the entry of DNA 
molecules into the cells and subsequent expression represent a very wasteful process [3]. The 
observation that free plasmid DNA is able to transfect he skeletal muscle [4] the liver [5] or a 
tumour [6] when given in the appropriate way, but will normally be degraded in the systemic 
circulation [7], provides the rationale for ‘packagin ’ of the DNA. This packaging occurs 
with the help of a delivery system that tends to compact and protect the nucleic acid [8-11].  
The rapidly rising demand for therapeutic grade DNA molecules requires associated 
improvements in encapsulation and delivery technologies. This includes the formulation of 
DNA molecules into synthetic delivery systems for enhanced cellular transformation 
efficiencies. Research works on colloidal delivery systems in genetic therapeutics are based 
on the molecular level focusing on the interdisciplinary development of pharmaceutical DNA 
delivery approaches. Colloidal delivery systems modify many physicochemical properties, 
aiming to protect the DNA from degradation, minimize DNA loss, prevent harmful side 
effects, enhance DNA targeting, increase drug bioavail bility, and stimulate the immune 
systems [12-17].   
The advances in strategies for treating a wide variety of diseases require an efficient 
delivery of the active compounds into the cytosol of target cells. One of the challenges for the 
efficient intracellular delivery of therapeutic biom lecules after their cell internalization by 
endocytosis is to manipulate the non-productive trafficking from endosomes to lysosomes, 
where degradation may occur. Endosomes are vesicles formed within a cell during forms of 
endocytosis in which the material to be ingested first binds to receptor sites on the cell 
surface. Because the nanocarriers generally cannot directly cross the lipid bilayer of the 
endosomes, the pH targeting approach, which can lead to a selective disruption of the 
endosomal membrane, is regarded as a promising strategy to promote a specific triggered 
release of active biomolecules. The combination of the endosomal acidity with the 
endosomolytic capability of the nanocarrier can increase the intracellular delivery of many 
drugs, genes and proteins, which, therefore, might en ance their therapeutic efficacy [18]. The 
intracellular delivery of active biomacromolecules from endosomes into the cytoplasm 
generally requires a membrane-disrupting agent. Since endosomes have a slightly acidic pH, 
pH sensitive compounds could be potentially useful for this purpose since they can destabilize 
membrane bilayers by pH-triggered conformational chnge. 
Gelatin forms thermally reversible gels with water, and the gel melting temperature 
(<35°C) is below body temperature, which gives gelatin products unique organoleptic 
properties and flavour release. Competitive gelling agents like starch, alginate, pectin, agar, 
carrageenan, etc. are all carbohydrates from vegetable sources, but their gels lack the melt in 
the mouth, elastic properties of gelatin gels. Gelatin is regarded as a food ingredient rather 
than an additive and it is Generally Regarded as Safe (GRAS). In 1993 the FDA reiterated the 
GRAS status of gelatin and stated that there was no objection to the use of gelatin from any 
source and any country provided that the hide from animals showing signs of neurological 
disease were excluded and also Specified Raw Materials were excluded from the 
manufacturing process [19]. The particularities rega ding the use of gelatin as a vehicle to 
release drugs into cells have been recently reviewed [20]. This review states that gelatin is one 
of the most versatile natural biopolymers. Due to is biocompatibility, low cost, 
biodegradability and varied available groups it is w dely used in pharmaceutical research for 
attaching targeting molecules.  
The gelification properties of gelatin as well as the strong dependence of gelatin ionization 
with pH makes this compound an interesting candidate to be used to the effective intracellular 
delivery of active biomacromolecules. Gelatin B, which pI is 4,8-5,2, is a negatively charged 
compound at physiological pH. This property might be used to form by interaction with 
oppositely charged compounds, keeping the protective structure until it enters into the cell. 
Once the particle enters the cell, where the pH of the endosome would decrease until pH 5, 
gelatin B becomes positively charged, and due to electrostatic repulsion within positive 
charges the protection ceases and the entrapped drug can be released into the cell. If 
appropriated, this hypothesis can be used to the effective intracellular delivery of DNA, RNA 
or other specific drug [21].  
Among the different strategies that can be used to form particles, the interaction between 
oppositely charged compounds has been selected. In this project, gelatin type B and 
protamine sulfate has been chosen. Protamine sulfate is protamine from salmon in the sulfate 
salt (PS), with a molecular mass of 5.1 kDa. Protamines are highly positively charged (overall 
charge +21), arginine rich proteins that bind to DNA in a non-specific manner via 
electrostatic interactions. Protamine sulfate adopts random coil conformation in solution. In 
addition, protein protamine sulfate has been shown to condense DNA [8, 22] and to deliver 
plasmid DNA into eukaryotic cells [23]. This property, in addition to its longtime use in 
pharmaceutical formulations, makes protamine a promising candidate in gene delivery 
formulations. Previous studies in our group has demonstrated the protamine sulfate, alone or 
in combination with the protein lysozyme, can be usd as biocompatible carriers to form 
DNA gel particles by interfacial diffusion [16, 24]. With regard of the use of protamine in 
biological systems, it is worth mentioning our recent results, summarising the effect of mixed 
protein-DNA gel particles systems on the DNA delivery and biocompatibility [16]  
In the present work, gelatin (either high or low gel strength) and protamine sulfate has been 
selected to form particles by interaction of oppositely charged compounds. Particles in the 
absence of DNA (binary system) and in the presence of DNA (ternary system) have been 
prepared. The physicochemical characterization (particle size, polydispersity index and degree 
of DNA entrapment) have been evaluated as a functio of the imposed composition. It is also 
important to figure out which properties govern theinteractions between these nanoparticles 
and cells. In vitro experiments have been performed in order to determin  the cytoxicity of the 
isolated systems and the resulting particles. The feasibility of this concept has been 
investigated by means of the pH-dependent hemolysis assay and the effect on size and DNA 
release of the nanoparticles co-incubated in buffers at defined pHs that mimic extracellular, 
early endosomal and late endo-lysosomal environments. 
 
2. Materials and methods 
2.1. Materials 
The gelatin from bovine skin (gelatine type B) with gel strength 225 and 75 g Bloom were 
purchased from Sigma and used as received. The protamine from salmon in the sulfate salt 
form (PS) with a molecular mass of 5.1 kDa were purchased from Sigma and used as 
received. The sodium salt of deoxyribonucleic acid (DNA) from salmon testes with an 
average degree of polymerisation of ≈2000 base pairs (bp) was purchased from Sigma and 
used as received. The DNA concentrations were determin d spectrophotometrically, 
assuming that for an absorbance of 1 at 260 nm, a solution of dsDNA has a concentration of 
50 μg/mL. The absorbance ratios at 260 and 280 nm of the s ock solutions were found to be 
between 1.8 and 1.9, which suggested the absence of proteins. N,N,N',N'-tetramethylacridine-
3,6-diamine (acridine orange (AO)) was supplied by Molecular Probes (Invitrogen). 2,5-
Diphenyl-3,-(4,5-dimethyl-2-thiazolyl) tetrazolium bromide (MTT), neutral red (NR) dye, and 
dimethylsulfoxide(DMSO) were obtained from Sigma–Aldrich. Dulbecco´s Modified Eagle´s 
Medium (DMEM), RPMI 1640 medium, fetal bovine serum (FBS), phosphate buffered saline 
(PBS), L-glutamine solution (200 mM), trypsin–EDTA solution (170,000 U/l trypsin and 0.2 
g/l EDTA), and penicillin–streptomycin solution(10,0 0 U/ml penicillin and 10 mg/ml 
streptomycin) were purchased from Lonza. The 75 cm2 flasks and 96-well plates were 
obtained from TPP. All other reagents were of analytical grade. 
2.2. Phase behaviour of gelatins in solution 
The phase behaviour of gelation in solution was examined by dissolution of gelatins in 
PBS buffer (pH 7.4) in a concentration range between 1 and 15 mg/mL. After magnetically 
stirring, the resulting solutions were kept overnight in the fridge (10 ºC), in order to promote 
the gel formation.   
2.3. Particle preparation  
Protamine sulfate (0.1-10 mg/mL) was dissolved in a PBS buffer (pH 7.4). DNA stock 
solutions were prepared in 10 mM NaBr to stabilize the DNA secondary structure in its native 
B-form conformation. In the case of binary systems, gelatin solutions (200 µL) were added 
dropwise into vigorously gently agitated protein soluti n (2 mL). Under optimal conditions, 
droplets from gelatin solutions broken under magnetically stirring and instantaneously gelled 
into discrete particles on contact with the cationic solution dipped into ice. Thereafter, the 
particles were equilibrated in the solutions for several periods (0-30 min). After these periods, 
the confirmation of the particle formation and the size distribution was determined by 
dynamic light scattering (DLS) at 25 ºC with a Zetasizer Nano ZS90. To measure the particle 
size distribution of the dispersion, a polydispersity index (PI), ranging from 0,0 for an entirely 
monodisperse sample to 1,0 for a polydisperse sample, is used. The interpretation of data is 
performed considering the size distribution by intensity of scattered light. 
In the case of ternary systems, mixed gelatin-DNA solutions (200 µL) were added 
dropwise into vigorously gently agitated protein soluti n (2 mL). The composition of DNA in 
the mixed systems was fixed at 50% (v/v) (unless otherwise stated). Under optimal 
conditions, droplets from the mixed gelatin/DNA solutions broken under magnetically stirring 
and instantaneously gelled into discrete particles on contact with the cationic solution dipped 
into ice. The confirmation of the particle formation and the size distribution was undertaken 
by means of a Zetasizer Nano ZS90, in a similar procedure of that described for particles 
prepared in the binary system.  
2.4. Determination of degree of DNA entrapment 
The degree of DNA entrapment in the nanoparticles derived from the ternary system was 
determined by quantifying the free DNA in the supernatant solution at 260 nm by means of a 
nanophotomeher (NanoPhotometerTM, Implen). In order to avoid some interference due to 
the nanoparticles, the nanoparticle dispersions were c ntrifugated at 10.000 rpm during 30 
min. Afterwards, a sample of the supernatant was remov d for quantification of the free DNA 
by spectrophotometry at 260 nm.  
The concentration of DNA bound in the DNA gel particles was calculated as the difference 
between the concentration of DNA added into the cationic solutions and the DNA that remain 
free in the solutions, after the nanoparticle formation: 
[bound DNA]= [total DNA] – [free DNA]     (1) 
The degree of DNA entrapment is expressed through the loading efficiency values. 
Loading efficiency (LE) is calculated by comparing the amount of DNA included in the 
particles with the total amount during particle formation. Loading efficiency (LE) were 
determined by the following equation: 
LE (%) = [bound DNA]/ [total DNA] x 100    (2) 
Three batches of particles were prepared in each system and the results are given as 
average and standard deviations. 
2.5. Cell cultures 
The murine Swiss albino fibroblast, 3T3 and the human epithelial carcinoma, HeLa cell 
lines were grown in DMEM medium (4.5 g L-1 glucose) supplemented with 10% (v/v) FBS, 2 
mM L-glutamine, 100 U ml-1 penicillin and 100 μg mL-1 streptomycin at 37ºC, 5% CO2. The 
3T3 and HeLa were routinely cultured in 75 cm2 culture flasks and were trypsinised using 
trypsin-EDTA when the cells reached approximately 80% confluence. 
2.6. Cytocompatibility assays  
The 3T3 (1 x 105 cell mL-1) and HeLa (5 x 104 cells mL-1,) were seeded into the central 60 
wells of a 96-well plate After incubation for 24 h under 5% CO2 at 37ºC, the spent medium 
was replaced in the wells with 100 μl of fresh medium supplemented with 5% FBS containing 
gelatin solutions at the required concentration range (50-2000 μg mL-1). In the case of the 
nanoparticles derived from the binary or ternary systems, 100 µL of each system diluted 1:1 
in fresh medium supplemented with 5% FBS was added in ach well. 
2.6.1. MTT assay 
The MTT assay is based on the protocol first described by Mossman [25]. In this assay, 
living cells reduce the yellow tetrazolium salt MTT to insoluble purple formazan crystals. 
After 3T3 and HeLa cell incubation for 24h, the nanoparticles derived from the the binary or 
ternary systems or the protein-containing medium were r moved and 100 μl of MTT in PBS 
(5 mg ml-1) diluted 1:10 in medium without FBS and phenol redwas then added to the cells. 
The plates were incubated for a further 3 h, after which the medium was removed. Thereafter, 
100 μl of DMSO was added to each well to dissolve the purple formazan product. Plates were 
then placed in a microtitre-plate shaker for 10 minat room temperature and the absorbance of 
the resulting solutions was measured at 550 nm using a Bio-Rad 550 microplate reader. The 
effect of each treatment was calculated as the percentage of tetrazolium salt reduction by 
viable cells against the untreated cell control (cells with medium only).  
2.6.2. NRU assay 
Based on the protocol described by Borenfreund and Puerner [26], the NRU assay 
determines the accumulation of the NR dye in the lysosomes of viable, undamaged cells. 
Following exposure to the nanoparticles derived from the the binary or ternary systems or the 
protein-containing medium were removed, and 3T3 and HeLa cells were incubated for 3h 
with NR dye solution (50 µg ml-1) dissolved in medium without FBS and phenol red. Cells 
were then washed with PBS, following by the addition of 100 µl of a solution containing 50% 
ethanol absolute and 1% acetic acid in distilled water to extract the dye. Plates were gently 
shaken for 10 min to ensure complete dissolution. We then measured the absorbance of the 
extracted solution at 550 nm using a Bio-Rad 550 microplate reader. The effect of each 
treatment was calculated as the percentage of uptake of NR dye by lysosomes against the 
untreated cell control (cells with medium only).  
2.7. Interaction with erythrocytes 
2.7.1. Preparation of red blood cell suspensions 
Rat blood was obtained from anaesthetized animals by cardiac puncture and drawn into 
tubes containing EDTA. This procedure was approved by the Ethical Committee for Animal 
Research of the University of Barcelona. Serum was removed from the blood by 
centrifugation at 3,000 rpm (Megafuge 2.0 R Heraeus Instruments) at 4ºC for 10 min, and 
subsequent suction. The red blood cells were then washed three times at 4ºC by centrifugation 
at 3,000 rpm with isotonic saline PBS solution, containing 22.2 mmol/L Na2HPO4, 5.6 
mmol/L KH2PO4 and 123.3 mmol/L NaCl in distilled water (pH 7.4). Following the last wash, 
the cells were diluted to ½ of their volume with isotonic phosphate buffer solution (PBS) (cell 
density of 8 x 109 cell mL-1). 
2.7.2.Hemocompatibility and endosomolytic characterization 
The membrane-lytic activity of the systems was examined by a hemolysis assay. Red blood 
cells and gelatin solutions were co-incubated in buffers at defined pHs that mimic 
extracellular (7.4), early endosomal (6.8), and late endo-lysosomal (< 6.8) environments.  A 
series of different volumes of the gelatin solutions (10 mg mL-1), ranging from 10 to 240 μL, 
were placed in polystyrene tubes and an aliquot of 25 μL of erythrocyte suspension was added 
to each tube. The final volume was 1 mL. The tubes w re incubated at room temperature for 1 
hour under shaking conditions using an Atom 190 shaker (Atom). Following incubation, the 
tubes were centrifuged (5 min at 10, 000 rpm). The degree of hemolysis was determined by 
comparing the absorbance (540 nm) (Shimadzu UV-160A) of the supernatant with that of the 
control samples totally hemolyzed with distilled water. Positive and negative controls were 
obtained by adding an aliquot of 25 µl of erythrocyte suspension to distilled water and 
isotonic PBS solution, respectively. 
2.8. Effect of environmental acidification on nanoparticles size and DNA release  
The effect of pH decrease from 7.4 to 5.0 (mimicking endosomal pH decrease) was 
investigated by DLS measurements. Particle size measur ments of the nanoparticles were 
performed at 25 °C with a Zetasizer Nano ZS90 (Malvern Instruments, Malvern). The 
nanoparticulate solutions were titrated from pH 7.4to pH 5.0 by regularly adding small 
aliquots of 0.25 M HCl solution.  
Simultaneously, the loading efficiency of the nanoparticles at intracellular pH was 
measured using solutions of nanoparticles prepared t the ternary system. After successive 
acidification to pH 5.0 by addition of  0.25 M HCl solution and incubation for 1 hour, the 
nanoparticles were centrifuged at 10,000 rpm for 30 min. Aliquots of supernatant were 
subsequently was removed for quantification of the fre  DNA by spectrophotometry at 260 
nm by means of a nanophotometer (NanoPhotometerTM, Implen). The percentage of loading 
efficiency was calculated from the difference of the total amount of DNA added to the 
solution and the amount of DNA that is determined in the free form in the supernatant. 
2.9. Statistical analyses 
Experiments were performed at least three times on independent occasions unless 
otherwise stated. Results are expresses as means standard error of the mean (SEM). Data were 
analyzed by PASW Statistics 18 software using one-way analysis of variance (ANOVA) with 
Scheffé post-hoc tests for multiple comparisons. Each experiment was performed at least 
three times on independent. Differences were considered statistically significant at p<0.05 or 




3. Results and discussion 
3.1. Phase behaviour of gelatins in solution 
In order to evaluate the conditions for which the formation of gels of gelatins are favoured, 
gelatins were dissolved in PBS buffer (pH 7.4) in a concentration range between 1 and 15 
mg/mL. The formation of the gels was examined by visual inspection and the stability of them 
was evaluated indirectly by inversion of the tubs. The formation and stability of the gels 
seems to be a function of the concentration, gelatin type and the corresponding bloom value. 
The formation of gels from gelatin type B75 and B225 takes place at concentration up to 11 
mg/mL. Regarding their stability, gels from gelatin type B225 demonstrated to be more stable 
with time than those obtained with the gelatin of lower gel strength (Fig. SM1).   
3.2. Particle formation at the gelatin B-protamine sulfate system (binary system) 
Once the phase behaviour of gelatins in solution was determined, the formation of 
nanoparticles at the water-water emulsion-type interfac s by interaction of oppositely charged 
compounds has carried out. For this purpose, gelatin type B, in its two different gel strength, 
and protamine sulfate has been chosen. The procedure to the particle formation at the binary 
systems started with the dropwise addition of a highly viscous gelatin B solution (10 mg/mL) 
to a protamine solution dipped into ice under stirring to promote the nanoparticle formation. 
Three different series of experiments have been performed in order to characterize the effect 
of the agitation time (0 and 30 min) and the ratio between the added gelatin and the protamine 
sulfate solution (10 and 20 % (v/v)), on the final properties of the obtained nanoparticles. In 
all cases, the effect of the protamine concentration was evaluated in varying the concentration 
of this protein from 0.1 to 1.0 mg/mL.  
When nanoparticles were prepared at the ratio gelatin type B225/protamine sulfate of 10% 
(v/v), a general trend can be observed: the size of the obtained particles increased 
progressively until reach a maximum and then started to decrease (Fig. 1a). This maximum on 
size corresponds to a protamine concentration equal to 0.5 mg/mL. The observed behaviour 
suggest that the incorporation of protamine sulfate on the obtained nanoparticles 
progressively increase until reach the concentration of 0.5 mg/mL. Afterwards, particle size 
decreased as a consequence of the higher compaction/ condensation degree as the 
concentration of the cationic agent increased. [16]. This is the general trend observed in the 
case of nanoparticles prepared with gelatine type B75, independently of the ratio gelatin 
B75/protamine sulfate (Fig.1c).  
When nanoparticles were prepared at the ratio gelatin type B225/protamine sulfate of 20% 
(v/v), a strong increase on particle size was observed. Although the size decreased as the 
protamine concentration increased, the higher size obtained under these conditions suggest 
that the inclusion of protamine sulfate on the particles seems to become more difficult (Fig. 
1a). The statistical analysis denotes only significant differences between the three treatments 
under certain conditions. In addition, when the effect of the gel strength of gelatin on the size 
and polydispersity index for the same experimental procedure is compared, no significant 
differences were obtained. 
 
Fig. 1 
As an indicator of the stability of the obtained nanoparticles at the binary system, a series 
of experiments were undergone in the presence of flu rescein as a model of hydrophilic drug. 
For this purpose, fluorescein was incorporated intothe gelatin type B solutions during its 
preparation. The resulting particles where observed through the fluorescence microscope (Fig. 
SM2). Under these conditions, only the substances able to emit under a specific wavelength 
excitation become visible. As shown in the figure, the fluorescent probe appears confined into 
the particles, confirming the success of the encapsul tion process. 
3.3. Particle formation at the gelatin B(DNA)-protamine sulfate system (ternary system) 
Once the stability of the particles resulting from the gelatin type B-protamine sulfate 
system was confirmed, as well as their ability to encapsulate substances such as fluorescein, 
the preparation of the particles at the gelatin B(DNA)-protamine sulfate systems were 
performed. One of the main objectives in this new serie  of experiments consisted in 
determining the maximum amount of DNA that can be incorporated in the gelatin type B 
solutions, preserving the homogeneity of the solutins. For this purpose, mixed solutions 
containing gelatin type B at a concentration equal to 10 mg/mL in PBS buffer (pH 7.4) and 
DNA at a concentration equal to 10 mg/mL in NaBr 10 mM solution were prepared. The 
composition of DNA in the mixed systems varied between 10 and 50% (v/v). Fluorescence 
microscopy using the fluorescence dye acridine orange (AO) was used to confirm the 
presence of DNA and to assess the secondary structure of the nucleic acid in the mixed 
solution. AO (excitation: 500 nm/emission: 526 nm) intercalates into double-stranded DNA as 
a monomer, whereas it binds to single-stranded DNA as an aggregate. On excitation, the 
monomeric acridine orange bound to double-stranded DNA fluoresces green, with an 
emission maximum at 530 nm. The aggregated acridine orange on single-stranded DNA 
fluoresces red, with emission at about 640 nm [27]. When the mixed solutions were examined 
by means of a transilluminator, fluorescence emission can be observed in the solutions, 
mainly in those systems in which the composition of DNA is up to 30% (v/v) (Fig. SM3 a). 
For lower DNA content (10 and 20% DNA (v/v)) it can be observed that DNA is not 
homogenously distributed on the gelatin type B soluti n. For DNA content between 40 and 
50% (v/v) homogeneous mixed gelatin/DNA systems can be obtained. Due to the 
homogeneity of the mixed systems as well as the stability of the obtained gels (Fig. SM3 b), 
the ration gelatin type B/DNA equal to 50% (v/v) was selected to perform subsequent 
experiments.   
The preparation of the nanoparticles at the ternary system was performed under the 
selected conditions. In a similar way of that performed at the binary system, the ratio gelatin 
type B225(DNA)/protamine sulfate was  equal to 10% (v/v) and the protamine concentration 
was varying from 0.1 to 1.0 mg/mL. It is noteworthy that once the mixed solutions gelatin 
type B/DNA came in contact with the protamine sulfate solutions, the formation of 
precipitates of big dimensions has been observed. It is known that interactions between 
oppositely charged compounds in aqueous solutions ca  lead to associative phase separation, 
where the concentrated phase assumes the form of a viscous liquid, gel, or precipitate. This 
approach was the basis for developing novel DNA-based materials, including DNA gel 
particles [17]. The presence of these precipitates, which were not observed in the case of the 
binary system gelatin type B -protamine sulfate, suggests that the interaction between DNA 
and protamine sulfate is more favoured.  
Although these results confirmed the formation of particles at the gelatin type B (DNA)-
protamine sulfate system, the size of the resulting particles were far away of the required 
dimensions to be applied for the intracellular delivery of active biomacromolecules. A 
progressive decrease on the concentration of both gelatin type B and DNA was performed in 
order to obtain almost colorless solutions confirming the generation of particles at the 
nanometric scale. Gelatin type B concentration was set at 0.25 mg/mL on varying the DNA 
concentration on the range between 0.125 and 1 mg/ml. For comparative purposes, particles 
in the absence of DNA (binary system) were also prepar d. The effect of protamine sulfate on 
the final properties of the obtained particles was evaluated by setting the protein concentration 
at 0.1 and 1.0 mg/mL. As can be observed in Figure 2a, the presence and concentration of 
DNA had no influence on the size of particles obtained at the gelatin type B(DNA)-PS0.1 
system. The obtained particles displayed a size around 250 nm. The effect of the gelatin gel 
strength can be also considered negligible. However, th  polydispersity index revealed the 
presence of DNA on the particles. The maximum pdI value corresponds to the particles 
prepared in the absence of DNA. Moreover, the pdI values decreased almost progressively 
when the DNA content increased. Significant differenc s between particles prepared at 
intermediate and high DNA concentrations and particles prepared in the absence of DNA 
were found (Fig. 2b).  No effect of the gelatin gelstrength has been observed. 
A different performance was observed when the concentration of protamine sulfate was 
increased ten times. Under these conditions, the siz of the obtained particles increased 
progressively when the DNA content increased. Significant differences between particles 
prepared at intermediate DNA concentrations and particles prepared in the absence of DNA 
were found (Figure 2c). The size varied between 100 nm, in the absence of DNA, and 500-
600 nm for the gelatin typeB(0.75DNA)-PS1.0 systems. These results can be correlated with 
an increase on the protamine sulfate inclusion on the particles.  For the highest DNA content, 
a decrease on the size is observed. This reduction on size can be correlated with an increase 
on the compaction/ condensation degree between the oppositely charged compounds DNA 
and protamine sulfate. Only under few experimental conditions significant differences 
between the gelatin gel strength were observed. 
In the present work, the observed pdI values resultd to be a function of the gelatin gel 
strength, DNA and PS concentration (see Fig. 2). However, the absence of presence of DNA 
on the formulations seems to be a controlling parameter of the PDI values. Nanoparticles 
prepared in absence of DNA demonstrated to show the highest pdI values (> 0.8) for both 
gelatin gel strength and both PS concentrations (Fig. 2 c and Fig. 2d). The results suggested 
that under these conditions, a broad polydisperse di tribution of nanoparticles have been 
obtained. However, in the presence of DNA, pdI values can be modulated from 0.2 to 0.8 by 
variation of the initial DNA concentration. In most cases, significant differences between PDI 
values corresponding to nanoparticles in the presence a d absence of DNA have been found, 
as indicated with a symbol mark (ǂp < 0.05 and ǂǂp < 0.005). Consequently, the initial DNA 
concentration on the formulations contributes positively to the moderate polydisperse 
distribution of the obtained nanoparticles.  In addition, when the effect of the protamine 
sulfate concentration on the size and polydispersity index obtained for the same experimental 
conditions (DNA concentration and gelatin gel strength) was compared, significant 
differences were obtained only under certain conditions (Figure 2e and 2f). 
By looking at the values of the polydispersity and size as a function of the PS/DNA 
concentration ratio, the optimal size with low polydispersity can be found. Using the data 
showed in Fig 2 is possible to deduct that for particles obtained at the gelatin type B(DNA)-
PS0.1, values of PS/DNA about 0.1-0.5 give the low polydispersity close to 0.2 while other 
values for the PS/DNA result in particles with high polydispersity. Consequently, DNA 
concentrations ranged between 0.5 and 1 mg/mL can be considered as the optimal DNA 
concentration values in terms of particle size and polydispersity values.  
The particle suspensions were investigated by TEM techniques without further 
purification. Although using this procedure most of the particles can appear embedded in the 
corresponding protein solution, it is possible to distinguish individual particles (indicated with 
black arrows, for cryoTEM and by white arrows, for negative staining TEM, Figure SM1). 
The sizes of the resulting nanoparticles are in good agreement with the experimental data 
determined by DLS techniques.  
3.4. Degree of DNA entrapment on the gelatin B(DNA)-protamine sulfate nanoparticles 
The success of the encapsulation process was evaluated as a basis of the DNA entrapment 
on the gel B (DNA)-PS nanoparticles.  The degree of DNA entrapment can be expressed as a 
function of the loading efficiency (LE) values. LE measures the amount of DNA that is 
included in the particles with respect to the total DNA, during particle formation.  
Fig. 3a and 3b summarize the characteristics of the nanoparticles obtained at the ternary. LE 
values ranged between 64 and 98% have been obtained for systems using protamine sulfate 
concentrations equal to 1.0 mg/mL. Interestingly, LE values reacted in a similar fashion when 
the protamine sulfate concentration was reduced ten times (LE ranged between 72 and 98%). 
The obtained LE values confirm the effectiveness of DNA entrapment under these conditions. 
When the effect of gelatin gel strength was evaluated for the same protamine sulfate 
concentration, significant differences between these two blooms values were obtained. The 
obtained results suggested that DNA entrapment is favoured when gelatin with the higher gel 
strength was used. When the effect of protamine sulfate for the same experimental conditions 
was compared, significant differences can be obtained: a protamine sulfate concentration 
equal to 0.1 mg/mL promoted higher LE values for the lowest and the highest DNA 
concentrations values; for protamine concentration equal to 1.0 mg/mL, higher LE values are 
obtained for discrete conditions (DNA concentration equal to 0.25 mg/mL) (Fig. 3c).  
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3.5. Cytotoxicity in vitro 
Cytotoxicity plays a critical role in the efficiency of the delivery vectors. In order to deliver 
the DNA into the cells, the cationic particles bind to the cell surface by electrostatic 
interaction, promote endocytosis and release the genetic material inside the cell. 
Unfortunately, while high concentrations of the deliv ry agents imply an increased chance of 
the DNA penetrating the cell nucleus, they can also interfere with physiological processes 
within the cell, inducing cell death. Thus, present research is aimed at designing gene delivery 
agents that are able to deliver DNA into the cells with minimal toxicity [28].  
The interaction of the obtained nanoparticles and their component was determined with 
non-tumor (3T3 fibroblast) and tumor (HeLa) cell lines. Assessing the capacity of live cells to 
metabolize a tetrazoliumcolorless salt to a blue formazan (MTT assay) as a measurement of 
cell metabolic activity within the mitrocondrial compartment, and the diffusion through intact 
cell membranes to accumulate within lysosomes (NRU assay) were used to perform indirect 
measurements of cell viability.  
The first approach on the determination of the cytotoxic response was performed with 
gelatins in solutions. Dose–response curves for each gelatin, determined by MTT and NRU 
assays using tumor cell line HeLa and non-tumor cell line 3T3 fibroblasts, are given in Fig. 
SM4. The cytotoxicity assays were performed in the concentration range 50 and 2000 μg/ mL.  
Gelatins showed low cytotoxicity towards HeLa cells, which displayed viability in the range 
77% to 100% and 84 and 100%, as determined by the MTT and NRU assays, respectively. 
Moreover, when the results obtained between the two different endpoints were compared, it 
can be deduced that the MTT assay was more sensitive in detecting the cytotoxic effects 
within the four studied gelatins than the NRU assay did. Similar results were obtained in the 
case of 3T3 cell line.  Due to the high viability observed at the tested protein concentrated 
range, it was not possible to define the protein cocentration required to inhibit cell growth by 
50% compared with an untreated control (IC50). Consequently, this value can be defined as 
higher than 2000 ug/mL for the two studied gelatins. The statistical analysis denotes only 
significant differences between the two endpoint points under certain conditions. 
Previous studies carried out in our group have reveal d that, as with other cationic 
derivatives, protamine sulfate displayed concentration-dependent toxicity towards cells in
vitro [16]. PS showed cell viabilities ranged from 7% to 100%, depending on the 
concentration. These experiments enabled us to define the protein concentration required to 
inhibit cell growth by 50% compared with an untreated control (IC50). For PS, it was found to 
be 140 and 250 μg/mL for 3T3 and HeLa cell lines, respectively. Concerning DNA/protamine 
complexes, studies performed with other authors demonstrated that those complexes have 
little cytotoxicity [29]. Consequently, the putative cytotoxic response of the gelatin-based 
nanoparticles can be derived from the contribution of the protamine sulfate.   
Once the relative viability of the isolated components was determined, the cytotoxic effect 
of the nanoparticles obtained at the ternary system was evaluated. Taking into account the 
obtained results concerning the particle size, the degree of DNA entrapment as well as the 
demonstrated cytotoxicity of protamine sulfate, thecytotoxic study was restricted to the 
ternary sytems prepared at a protamine concentration equal to 0.1 mg/mL. For comparative 
purposes, particles in the absence of DNA (binary system) were also tested. Fig. 4 
summarizes the obtained results as a function of the cell line and endpoint assay.  
  A general trend in the cytotoxicity responses of the nanoparticles prepared at the ternary 
system is that the cell viabilities provided by these systems showed lower values that those 
observed by nanoparticles obtained in the absence of DNA (binary systems). Although the 
molecular details of the mechanism by which cationic carriers mediate DNA delivery are still 
poorly understood, current evidence supports the hypot esis that the DNA complexes enter 
cells by means of endocytosis. The efficiency of cellular uptake and subsequent intracellular 
processing, a prerequisite for effective cellular tr nsfection, may well depend on particle size.  
In this work, the physicochemical characterization of the obtained particles, including their 
size distribution was performed (Figure 2). Although the nanoparticles prepared in the 
absence of DNA showed higher polydispersity than the DNA-containing nanoparticles, both 
series of nanoparticles were obtained in a size range for which significant differences have not 
observed.  
The observed differences on cell viability as a function of the DNA concentration seem to 
be a function of both the cell line and the endpoint assays. When 3T3 fibroblasts were used, 
significant differences between particles prepared in presence and absence of DNA were 
found, by the MTT assay (Figure 4a). The cell viabil ties varied between 45 and 75 % as a 
function of DNA and gelatin gel strength. Remarkably, cell viabilities ranged between 100 
and 160 % were observed using the NRU assay (Figure 4b). No significant differences 
between particles prepared in presence and absence of DNA were found were observed. 
When HeLa cell line was used, significant differencs between particles prepared in presence 
and absence of DNA were found, by both the MTT and NRU assay (Figure 4c and 4d). The 
cell viabilities varied between 45 and 100 % for MTT and 17 and 100% for NRU, as a 
function of DNA and gelatin gel strength. Interestingly, the studied endpoints assays appeared 
to be selective to the deleterious effect of nanoparticles prepared with different gelatine gel 
strength. Whereas MTT assay seems to be more sensitiv  to the effects of nanoparticles 
prepared with gelatin with the lower gel strength value, NRU discriminated better between the 
effects of nanoparticles prepared with gelatin with the higher gel strength.  
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In addition, the cytotoxic properties of the obtained nanoparticles were evaluated in order 
to establish selective responses as a function of cell line type and endpoint method (Fig. 5). 
When the effect of the endpoint method was evaluated in 3T3 cell line (Fig.5a), greater 
cytotoxicity have been detected by MTT than by NRU endpoint. It is well established that the 
MTT assay is a measurement of cell metabolic activity within the mitochondrial 
compartment, while NRU assay measure membrane integrity. NR dye diffuses through intact 
cell membranes to accumulate within lysosomes [30, 31]. Based on the mechanisms of cell 
damage detected by each cytotoxicity assay, the obtained results suggested that the toxicity 
mechanism of nanoparticles obtained at the binary and ternary systems involve an earlier 
interaction with the mitochondrial compartment while the plasma membrane and/or lysosomal 
compartments could be affected at a later stage. Under these conditions, almost in all cases 
there are significant differences between the obtained values by MTT and NRU methods 
(p<0.05 and p<0.005). No significant differences were found when the effect of gel strength 
on the cytotoxic responses of nanoparticles prepared under the same experimental conditions 
was compared.   
In contrast, more significant differences between na oparticles prepared with gelatin with 
different gel strength were observed with Hela cell line (Fig.5b). Together with some 
significant differences on the cell viabilities observed as a function of the endpoint method, 
for which MTT seems to promote higher cytotoxic responses, differences between the 
cytotoxic responses promoted by nanoparticles prepared with different gelatin gel strength 
could be establish under discrete conditions. In the case of nanoparticles prepared in the 
absence of DNA (binary system), higher cytotoxic responses were detected for the 
formulations containing the gelatin with higher gelstrength, especially with the MTT method. 
In contrast, higher cytotoxic responses were observed in the case of the nanoparticles 
prepared with the lower gelatin gel strength at theDNA concentration of 0.5 mg/mL 
determined by the NRU method.  
When the results obtained between the two different endpoints were compared, it could be 
deduced that, in general, the NRU assay gave higher cell viabilities than the MTT assay did 
(Fig.5c and 5d). However, the latter assay was more sensitive in detecting the effect of gelatin 
gel strength on particles prepared in the absence of DNA (binary systems) (Fig. 5c). These 
results suggest that the nanoparticles prepared with gelatin with higher gel strength have a 
greater effect on the metabolic activity than on plasma membrane on the cells, especially in 
the case of the HeLa cell line. In contrast, by NRU methods, HeLa cells seem to be more 
sensitive to the deleterious effect of nanoparticles prepared in presence of DNA (0.5 mg/mL 
of DNA) and gelatin with the lower gel strength. Therefore it can be concluded that the 
tumoral cell line HeLa seems to be more sensitive to the effect of gelatin gel strength, 
presence or absence of DNA on the particles and endpoi t method.  
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3.6. Hemocompatibility and endosomolytic characterization 
One useful model system for screening endosomolytic behavior is the ex vivo pH-
dependent hemolysis assay. In this model system, the erythrocyte membrane served as a 
surrogate for the lipid bilayer membrane that encloses endolysosomal vesicles. This 
generalizable model has been used by others to evaluate the endosomolytic behavior of cell-
penetrating peptides and other polymeric gene delivery systems [32-35]. 
In this protocol, red blood cells and test materials were co-incubated in buffers at defined 
pHs that mimic extracellular (7.4), early endosomal (6.8), and late endo-lysosomal (< 6.8) 
environments.  From screening a small library of potentially endosomolytic test materials, one 
can infer that samples that produce no hemolysis at pH 7.4, but significantly elevated 
hemolysis at pH < 6.5, will be the most effective and cytocompatible candidates for cytosolic 
drug delivery. Materials that fit these criteria would be expected to remain inert and not 
indiscriminately destroy lipid bilayer membranes until being e6xposed to a drop in the local 
pH following internalization into endolysosomal compartments [36]. 
Red blood cells were co-incubated at pH 5.0, 5.6, 6.0, .4, 6.8 and 7.4 with gelatin type 
B225 and gelatin type B75 at the range of concentration from 100 to 2400 μg/mL (Fig.6). In 
these experiments two types of information can be derived. First of all, the haemolytic 
potential of a material can be defined as the measur  of the extent of haemolysis that may be 
caused by the system when it comes into contact with blood. Accordingly, the results obtained 
at pH 7.4 make possible the evaluation of the haemolytic character of these two gelatins. 
From a haemolytic point of view, values lower than 5% can be considered a permissible level 
[37]. Taking into account the obtained results, gelatin type B225 seems to be slightly 
haemolytic at concentrations of 800 and 1600 μg/m. However, the haemolytic values obtained 
with gelatin type B75 were always lower than the permissible level.  
The haemolysis assay could be also used as rapid screen for endosomolytic activity of 
intracellular drug delivery systems. In the hemolysis assay, red blood cells and gelatins were 
incubated in PBS buffer at defined pH that mimics extracellular, early endosomal, and late 
endolysosomal enviroments. In this model system the erythrocyte membrane serves as a 
surrogate for the lipid bilayer membrane that encloses endolysosoma vesicles. Typically, ideal 
endosomolytic agents exhibit dose-dependent and pH-ependent hemolytic behavior. Figure 
7a shows the hemolytic responses of gelatin type B225 at the selected pH values. Under the 
studied conditions, gelatin type B225 showed a concentration-dependent haemolysis. 
However, concerning the pH dependence, it seems to be a function of the gelatin 
concentration. If for 100 and 2400 µg/mL, the haemolytic response increase as the pH value 
decrease, for intermediate concentration, the opposite trend could be observed. The gel 
strength of the gelatin derivative also plays an important role on the assignment of 
endosomolytic activity though the haemolysis assay. When the effect of pH on the haemolytic 
response of red blood cells to gelatin type B has been determined, the effect of both 
concentration and pH is observable. Concerning the later, the hemolysis responses seem to 
perform in the expected way for concentrations equal to 100 and 1600 µg/mL, being the 
opposite at 800 µg/mL.  
Interestingly, at the highest studied concentration, negative haemolysis values were 
obtained. These results, lacking in meaning concerning haemolysis,were in connection with 
the fact that gelatins can form gels, for which adsorption of the media can be expected. In the 
light of these considerations, it seems that at the highest studied concentration, gelatin type 
B75 was able to adsorb the haemoglobin released into the media by effect of the gelatin, in 
comparison with the untreated erythrocytes control (erythrocytes only with medium at the 
corresponding pH values). The obtained results demonstrated that the higher the pH the 
greater the adsorption is. These results can be correlated with the ionization state of 
haemoglobin as a function of pH.  Human haemoglobin shows a pI around 7.1 [38].  
Assuming that this value would be similar in the case of haemoglobin derived from 
erythrocytes from rat, the released haemoglobin would present a positive charge in almost all 
the studied pH interval. Gelatin type B, however, would present a negative charge until pH 
values close to 5, for which the change of ionization state would occurs. Consequently, there 
is a pH interval for which haemoglobin and gelatin type B presented opposite charges, 
favouring the electrostatic interaction between them and increasing the adsorption. For pH at 
values close to pH 5, both proteins would present positive charges, minimizing the 
electrostatic interaction between them and, consequently, modulating the adsorption. 
Statistical analyses didn’t denote significant differences between the haemolytic results at 
different pH values.  
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3.7. Effect of environmental acidification on nanoparticles  size and DNA release  
 
Since electrostatic interactions between the negatively-charged gelatin type B and the 
positively-charged protamine sulfate are the main dr ving force for the self-assembly into the 
nanoparticles, it can be anticipated that a decrease in pH, as is occurring during endosomal 
acidification, would influence the stability of the nanoparticles. A decrease of the pH would 
also lead to destabilization and eventually release of DNA from the nanoparticles prepared at 
the ternary system [39]. 
DLS measurements showed that the gelatin type B75-PS nanoparticles significantly 
increase in size from ca. 300 nm to 700 nm when the pH decreases from 7.4 (extracellular 
pH) to 5.0 (intracellular pH). In contrast, no effect was observed in the case of gelatin type 
B225-PS nanoparticles (Figure 7a). These results are in the light of that observed when the 
endosomolytic response was determined by means of the haemolysis assay (Fig. 6). In 
comparison, the corresponding DNA-containing nanoparticles slightly responded to pH 
decrease. In general, a discrete increase on size of less than 100 nm could be observed by 
acidification from extracellular to intracellular pH values. This result may be attributed to the 
strong interaction between DNA and protamine sulphate, as was already described. 
Significative differences between size values for pH 7.4 and pH 5.0 were found in discrete 
cases (Figure 7a). The final size variation between xtracellular and intracellular pH as a 
function of the initial DNA concentration is summarized in Fig. 7b.  
The DNA release from the gelatin type B (DNA)-PS nanoparticles by acidification from 
pH 7.4 (extracellular pH) to pH 5.0 (intracellular pH) is summarized in Fig. 8. The DNA 
release upon successive acidification seems to be a function of both the gelatin gel strength as 
well as the initial DNA concentration. A general trend is that the DNA released from 
nanoparticles increased progressively for pH values corresponding to early to late endosomes. 
However, in the case of nanoparticles prepared withgelatin type B225 the DNA released 
seems to start to pH values corresponding to early endosomes (pH 6.8). The percentage of 
DNA released result to be a function of both the gelatin gel strength and the initial DNA 
concentration. The percentage of DNA released decreased exponentially as a function of the 
initial DNA concentration, with percentages of DNA released ranged  between 50 to 15 % , 
and 40 and 10%, for nanoparticles prepared with gelatin type B225 and gelatin type B75, 
respectively (Fig. 8b). The maximum amount of DNA released from the nanoparticles is 12 
and 17 µg/mL for nanoparticles containing gelatin type B75 and gelatin type B225, 






The interaction between oppositely charged compounds has been the basis for developing 
gelatin-based nanoparticles. By mixing solutions of gelatin type B (either high or low gel 
strength) with solutions of protamine sulfate the formation of nanoparticles with sizes around 
400 nm but high polydispersity has been obtained. .As a first requirement for systems to 
function as intracellular delivery vectors is that they should be able to condense their content 
into nanosized particles. Both the size (around 200 nm) and the polydispersity were strongly 
decreased when DNA was included on the nanoparticles formulations (ternary systems). DNA 
was effectively entrapped on the gelatin B(DNA)-protamine sulfate nanoparticles with LE 
values ranged between 72 and 98%, confirming the eff ctiveness of the encapsulation 
process.  
Cytotoxicity plays a critical role in the efficiency of the delivery vectors. The interaction of 
the obtained nanoparticles and their component was determined with non-tumor (3T3 
fibroblast) and tumor (HeLa) cell lines, using MTT and NRU assays to perform indirect 
measurements of cell viability. Whereas gelatin type B resulted to be non-cytotoxic in nature, 
with IC50 values higher than 2000 ug /mL, the putative cytotoxicity of the obtained 
nanoparticles seems to be a function of the inclusion of protamine sulfate. A general trend in 
the cytotoxicity responses of the nanoparticles prepar d at the ternary system is that the cell 
viabilities provided by these systems showed lower values that those observed by 
nanoparticles obtained in the absence of DNA (binary systems). The cytotoxic properties of 
the obtained nanoparticles were evaluated in order to establish selective responses as a 
function of cell line type and endpoint method. It can be concluded that the tumoral cell line 
HeLa seems to be more sensitive to the effect of gelatin gel strength, presence or absence of 
DNA on the particles and endpoint method.  
The hemolysis assay has been demonstrated to be a useful model for screening the 
endosomolytic behaviour of gelatins in solution. Byco-incubation of red blood cells with 
gelatin solutions in buffers at defined pHs that mimic extracellular and intracellular 
environments, the effect of pH has been evaluated. Gelatins resulted to be non-haemolytic 
compounds with haemolysis values lower than 5 % at physiological pH. When the 
nanoparticles were inserted in buffer solutions that re ches pH endosomal values (pH ~5), 
different responses have been encountered: particle destabilization, size modification and 
DNA release. Upon acidification of the solution, as occurs after endosomal uptake, the gelatin 
B(DNA)-protamine sulfate nanoparticles tend to destabilize as is evidenced from their 
observed increase in size in DLS experiments. DNA can be effectively released, with 
maximum percentages ranged between 40 and 50% DNA released, as a function of both the 
gelatin gel strength and the initial DNA concentration. The results indicate that these gelatin-
based nanoparticles have excellent properties as highly potent and non-toxic intracellular 
delivery systems, rendering them promising DNA vehicles to be used as non-viral gene 
delivery systems. Current studies are focused on determining the mechanism of nanoparticles 
uptake and internalization. 
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Fig. 1. Effect of protamine sulfate concentration and prepaation method on the size and 
polydispersity index, respectively of nanoparticles obtained with gelatin type B225 (a,b) and gelatin 
type B75 (c,d). The data correspond to the average of three independent experiments ± standard 
deviation. Statistical analyses were performed using ANOVA followed by Scheffé’s multiple 
comparison test; *p < 0.05 denotes significant differences. 
 
Fig. 2. Effect of DNA concentration and bloom strength on the size and polydispersity index, 
respectively of nanoparticles obtained with protamine sulfate at 0.1 mg/mL (a,b) and protamine sulfate 
at 1.0 mg/mL (c,d). Effect of protamine sulfate cone tration on the size (e) and polydispersity index 
(f) of nanoparticles prepared under the same DNA concentration and gelatin bloom strength. The data 
correspond to the average of three independent experiments ± standard deviation. Statistical analyses 
were performed using ANOVA followed by Scheffé’s multiple comparison test; ‡p < 0.05 denotes 
significant differences regarding particles formed in the absence of DNA (binary systems),  **p < 
0.005 denotes significant differences regarding particles formed under the same experimental 
conditions with different gelatin gel strength, and §p<0.05 and §§p<0.005 denotes significant 
differences regarding particles formed under the same experimental conditions with different 
protamine sulfate content. 
 
Fig. 3. Effect of DNA concentration and bloom strength on the loading efficiency (LE) values of 
nanoparticles obtained with protamine sulfate at 0.1 mg/mL (a) and protamine sulfate at 1.0 
mg/mL(b). Effect of protamine concentration on the loading efficiency (LE) values of nanoparticles 
obtained for the same DNA concentration and bloom strength (c).  The data correspond to the average 
of three independent experiments ± standard deviation. Statistical analyses were performed using 
ANOVA followed by Scheffé’s multiple comparison tes; **p < 0.05 denotes significant differences 
between different gelatin gel strength and ǂǂp <0.005 denotes significant differences between different 
protamine sulfate concentration. 
 
Fig. 4. Effect of DNA concentration and bloom strength on the relative viabilities of 3T3 (a, b)  and 
HeLa (c, d) cells  treated with the different nanoparticles during 24h determined by MTT and NRU  
assays, respectively. The data correspond to the average of three independent experiments ± standard 
deviation. Statistical analyses were performed using ANOVA followed by Scheffé’s multiple 
comparison test, ǂp < 0.05 and ǂǂp < 0.005 denotes significant differences regarding particles prepared 
in the absence of DNA (binary systems). 
 
Fig. 5. Cell viabilities on 3T3 (a) and HeLa (b) cell lines on varying the endpoint method, and cell 
viabilities determined by MTT (c) and NRU (d) methods on varying the cell line type.  The data 
correspond to the average of three independent experiments ± standard deviation. Statistical analyses 
were performed using ANOVA followed by Scheffé’s multiple comparison test; *p < 0.05 and **p < 
0.005 denotes significant differences. 
 
Fig. 6. Effect of pH and concentration on the haemolytic responses of gelatin type B225 (a) and 
gelatin type B75 (b). The data correspond to the average of three independent experiments ± standard 
deviation.  
Fig. 7. Effect of acidification from pH 7.4 (extracellular pH) to pH 5.0 (intracellular pH) on the size of 
the nanoparticles prepared in absence (binary systems) and presence of DNA (ternary systems) (a). 
The data correspond to the average of three indepennt experiments ± standard deviation.  Statistical 
analyses were performed using ANOVA followed by Scheffé’s multiple comparison test, ǂp < 0.05 
and ǂǂp < 0.005 denotes significant differences regarding size values obtained a pH 7.4 (extracellular 
pH). Size variation (times) from pH 7.4 (extracellular pH) to pH 5.0 (intracellular pH) as a function f 
the initial DNA concentration (b). The data correspond to the average of three independent 
experiments ± standard deviation.   
Fig. 8. Effect of acidification from pH 7.4 (extracellular pH) to pH 5.0 (intracellular pH) on the release 
of DNA from nanoparticles (a). The data correspond to the average of three independent experiments 
± standard deviation. Percentage of DNA released from the nanoparticles from pH 7.4 (extracellular 
pH) to pH 5.0 (intracellular pH) as a function of the initial DNA concentration (b). Amount of DNA 
released from the nanoparticles from pH 7.4 (extracellular pH) to pH 5.0 (intracellular pH) as a 
function of the initial DNA concentration (c). The data correspond to the average of three independent 
experiments ± standard deviation. 
 
 
 
 
 
 
 
